Should You Buy Sanofi SA (SNY) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast SNY stock price to rise
5 Analyst Rating
Wall Street analysts forecast SNY stock price to rise
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 44.290
Low
57
Averages
79.36
High
119.07
Current: 44.290
Low
57
Averages
79.36
High
119.07
Morgan Stanley
Overweight -> Equal Weight
downgrade
$55 -> $52
AI Analysis
2026-05-01
Reason
Morgan Stanley
Price Target
$55 -> $52
AI Analysis
2026-05-01
downgrade
Overweight -> Equal Weight
Reason
Morgan Stanley downgraded Sanofi to Equal Weight from Overweight with a price target of $52, down from $55. Q1 results support upside to 2026 numbers and scope for a Q2 guidance raise, but \"the equity story remains catalyst-light\" with key pipeline readouts now in 2027, the analyst tells investors. The analyst added that \"cheap valuation alone may not close the discount.\"
BNP Paribas
Peter Verdult
Outperform
to
Neutral
downgrade
$50
2026-04-20
Reason
BNP Paribas
Peter Verdult
Price Target
$50
2026-04-20
downgrade
Outperform
to
Neutral
Reason
BNP Paribas analyst Peter Verdult downgraded Sanofi to Neutral from Outperform with a $50 price target. The firm cites its revised pipeline assumptions for the downgrade. A \"near-term rerating story is unlikely,\" the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SNY
